Andere talen Biogen Inc. Sao Paulo

Aandelen

BIIB34

BRBIIBBDR001

Beurs gesloten - Sao Paulo Andere beurzen 16:25:03 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
171,4 ^BRL	-2,16%		-.--%	-16,49%

13:00	Adviseurs Amerikaanse FDA gaan medicijn van Eli Lilly tegen Alzheimer beoordelen	RE
09:44	Biogen, Eisai zeggen dat aanvraag voor onderhoudsbehandeling van Alzheimer is geaccepteerd door Amerikaanse FDA	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

US FDA advisers to review Eli Lilly Alzheimer's drug	13:00
Lost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm	11:46
Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA	09:44
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease	01:38
FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease	01:31
Biogen Inc. Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP	08/06
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses to Contact the Firm	07/06
US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug	06/06
Italien hat Novartis und weitere Pharmafirmen wegen Augenarznei im Visier	06/06
Italienische Wettbewerbsbehörde nimmt vier Pharmakonzerne ins Visier	06/06
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	06/06
Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB	06/06
Novartis and others face Italy antitrust probe over eye drug	06/06
FINAL DEADLINE RAPIDLY APPROACHING: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm	05/06
Investors who lost money on Biogen Inc. (BIIB) should contact The Gross Law Firm about pending Class Action - BIIB	05/06
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)	04/06
Class Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join - Contact Levi & Korsinsky	04/06
Robbins LLP Urges BIIB Investors With Large Losses to Contact the Firm for Information About the Biogen Inc. Class Action	04/06
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)	03/06
Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel	03/06

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biogen Inc. Sao Paulo

Aandelen

BIIB34

BRBIIBBDR001

Andere talen

Filters